Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy

Table 5 Estimated risk (%) for each case of preeclampsia for each model at a fixed FPR of 10%

Cases ID	PAPP-A + Inhibin A	PAPP-A + sFlt-1/PlGF¹	PAPP-A + sFlt-1/PlGF²	BMI + sFlt-1¹	sFlt-1/PlGF¹+ sFlt-1/PlGF²	Pattern*
38	4.43	2.59	55.44	0.79	7.25	0	0	1	0	1
51	18.64	4.76	2.62	5.30	0.64	1	1	1	1	0
147	2.86	5.40	1.62	51.4	19.85	0	1	0	1	1
137	36.53	33.60	38.30	19.1	31.95	1	1	1	1	1
144	2.96	36.02	3.11	42.9	20.90	0	1	1	1	1
4	0.59	99.32	1.88	40.3	97.83	0	1	0	1	1
218	5.46	99.99	80.35	20.8	99.99	1	1	1	1	1
153	26.96	100	99.92	30.6	100	1	1	1	1	1

*0 = missed case, 1 = detected case.
PAPP-A: pregnancy-associated plasma protein-A, sFlt-1¹: second trimester sFlt-1, PlGF¹: second trimester PlGF, sFlt-1/PlGF¹: second trimester sFlt-1/PlGF ratio, sFlt-1²: third trimester sFlt-1, PlGF²: third trimester PlGF, sFlt-1/PlGF²: third trimester sFlt-1/PlGF ratio.

ISSN: 1471-2393